JAAD Game Changers: Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients

JAAD Game Changers: Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American Academy of Dermatology 2024-11, Vol.91 (5), p.825-825
1. Verfasser: Wohltmann, Wendi E.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 825
container_issue 5
container_start_page 825
container_title Journal of the American Academy of Dermatology
container_volume 91
creator Wohltmann, Wendi E.
description
doi_str_mv 10.1016/j.jaad.2024.05.064
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3063471571</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0190962224008272</els_id><sourcerecordid>3063471571</sourcerecordid><originalsourceid>FETCH-LOGICAL-c307t-b4181887379527cd300a1f4e8352bc8fa207a588802d1db92bfae85d078879c13</originalsourceid><addsrcrecordid>eNp9kE1v1DAURa0K1A6FP8ACeckm4dlOYgexGQ1QQJW6adfWi_1CPZp8YHtG6r9voiksWd3FO_dK7zD2XkApQDSf9uUe0ZcSZFVCXUJTXbCNgFYXjTb6FduAaKFoGymv2JuU9gDQVkpfsitljFSNaTZs_rXdfuU3OBDfPeL4m2L6zO-nHl3IYQwd76fI8yPxHAnzQGPmU88TnSgSx8M0kwvIcT0uMXp-whhwzMvKlqd89E8r3wKfMYelnd6y1z0eEr17yWv28P3b_e5HcXt383O3vS2cAp2LrhJGGKOVbmupnVcAKPqKjKpl50yPEjTWxhiQXviulV2PZGoPeim1Tqhr9vG8O8fpz5FStkNIjg4HHGk6JqugUZUWtV5ReUZdnFKK1Ns5hgHjkxVgV9N2b1fTdjVtobaL6aX04WX_2A3k_1X-ql2AL2eAli9PgaJNbjHgyIdILls_hf_tPwM4Z43Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3063471571</pqid></control><display><type>article</type><title>JAAD Game Changers: Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients</title><source>Elsevier ScienceDirect Journals Complete</source><creator>Wohltmann, Wendi E.</creator><creatorcontrib>Wohltmann, Wendi E.</creatorcontrib><identifier>ISSN: 0190-9622</identifier><identifier>ISSN: 1097-6787</identifier><identifier>EISSN: 1097-6787</identifier><identifier>DOI: 10.1016/j.jaad.2024.05.064</identifier><identifier>PMID: 38823686</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><ispartof>Journal of the American Academy of Dermatology, 2024-11, Vol.91 (5), p.825-825</ispartof><rights>2024</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><orcidid>0000-0002-8293-1217</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0190962224008272$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38823686$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wohltmann, Wendi E.</creatorcontrib><title>JAAD Game Changers: Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients</title><title>Journal of the American Academy of Dermatology</title><addtitle>J Am Acad Dermatol</addtitle><issn>0190-9622</issn><issn>1097-6787</issn><issn>1097-6787</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp9kE1v1DAURa0K1A6FP8ACeckm4dlOYgexGQ1QQJW6adfWi_1CPZp8YHtG6r9voiksWd3FO_dK7zD2XkApQDSf9uUe0ZcSZFVCXUJTXbCNgFYXjTb6FduAaKFoGymv2JuU9gDQVkpfsitljFSNaTZs_rXdfuU3OBDfPeL4m2L6zO-nHl3IYQwd76fI8yPxHAnzQGPmU88TnSgSx8M0kwvIcT0uMXp-whhwzMvKlqd89E8r3wKfMYelnd6y1z0eEr17yWv28P3b_e5HcXt383O3vS2cAp2LrhJGGKOVbmupnVcAKPqKjKpl50yPEjTWxhiQXviulV2PZGoPeim1Tqhr9vG8O8fpz5FStkNIjg4HHGk6JqugUZUWtV5ReUZdnFKK1Ns5hgHjkxVgV9N2b1fTdjVtobaL6aX04WX_2A3k_1X-ql2AL2eAli9PgaJNbjHgyIdILls_hf_tPwM4Z43Q</recordid><startdate>20241101</startdate><enddate>20241101</enddate><creator>Wohltmann, Wendi E.</creator><general>Elsevier Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-8293-1217</orcidid></search><sort><creationdate>20241101</creationdate><title>JAAD Game Changers: Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients</title><author>Wohltmann, Wendi E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c307t-b4181887379527cd300a1f4e8352bc8fa207a588802d1db92bfae85d078879c13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wohltmann, Wendi E.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of the American Academy of Dermatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wohltmann, Wendi E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>JAAD Game Changers: Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients</atitle><jtitle>Journal of the American Academy of Dermatology</jtitle><addtitle>J Am Acad Dermatol</addtitle><date>2024-11-01</date><risdate>2024</risdate><volume>91</volume><issue>5</issue><spage>825</spage><epage>825</epage><pages>825-825</pages><issn>0190-9622</issn><issn>1097-6787</issn><eissn>1097-6787</eissn><cop>United States</cop><pub>Elsevier Inc</pub><pmid>38823686</pmid><doi>10.1016/j.jaad.2024.05.064</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0002-8293-1217</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0190-9622
ispartof Journal of the American Academy of Dermatology, 2024-11, Vol.91 (5), p.825-825
issn 0190-9622
1097-6787
1097-6787
language eng
recordid cdi_proquest_miscellaneous_3063471571
source Elsevier ScienceDirect Journals Complete
title JAAD Game Changers: Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-11T01%3A56%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=JAAD%20Game%20Changers:%20Tofacitinib%20for%20the%20treatment%20of%20severe%20alopecia%20areata%20and%20variants:%20A%20study%20of%2090%20patients&rft.jtitle=Journal%20of%20the%20American%20Academy%20of%20Dermatology&rft.au=Wohltmann,%20Wendi%20E.&rft.date=2024-11-01&rft.volume=91&rft.issue=5&rft.spage=825&rft.epage=825&rft.pages=825-825&rft.issn=0190-9622&rft.eissn=1097-6787&rft_id=info:doi/10.1016/j.jaad.2024.05.064&rft_dat=%3Cproquest_cross%3E3063471571%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3063471571&rft_id=info:pmid/38823686&rft_els_id=S0190962224008272&rfr_iscdi=true